Find Academic Supervisors

• Dermatology
• Genodermatoses
• Inherited Skin Disorders
• +3 more

Dr. Xingyuan Jiang is a Postdoctoral Associate in the Department of Dermatology at Yale School of Medicine, working in Dr. Keith Choate's laboratory. Her research focuses on genodermatoses, with particular emphasis on uncovering the molecular mechanisms underlying congenital and mosaic skin disorders. Dr. Jiang received her medical education at Peking University, where she earned her MBBS degree in 2020 followed by her MD in Dermatology in 2023. During her training at Peking University, she completed dermatology residency and conducted research on inherited skin disorders, identifying novel pathogenic variants involved in keratinization and pigmentation diseases. Her research interests center on genetic skin disorders, with particular focus on keratinization and pigmentation diseases. Dr. Jiang employs molecular and translational approaches to explore targeted therapeutic strategies for rare syndromic and mosaic skin conditions. She utilizes advanced genetic and genomic techniques to identify novel pathogenic variants and understand their functional consequences in skin biology. Dr. Jiang's publication record demonstrates a consistent focus on palmoplantar keratodermas, epidermal nevi, and other genetic skin conditions. Her research has identified novel genetic variants associated with these conditions and explored potential therapeutic interventions, including JAK inhibitors for inflammatory skin disorders. She frequently collaborates with researchers including Keith Choate, Ryland Mortlock, Christine Ko, Christopher Bunick, and Ivan Lomakin. Dr. Jiang is actively contributing to the field of dermatogenetics through her research in Dr. Choate's laboratory at Yale. Her work bridges basic science and clinical applications, with the goal of developing personalized treatments for patients with rare genetic skin disorders.

• Epidermolysis Bullosa
• Genodermatoses
• Neurofibromatosis
• +3 more

Tobias Welponer is a researcher at the Department of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria, where he leads the Research Program of Molecular Therapy of Genodermatoses at the Salzburger Landeskliniken (SALK). His work bridges clinical dermatology and genetic research, focusing on improving therapeutic strategies and patient outcomes for rare skin disorders through translational science and collaborative networks. His primary research interests center on Epidermolysis Bullosa (100% of his fingerprint), with significant contributions to Neurofibromatosis Type I, pruritus management, and quality-of-life assessments in genodermatoses. Recent work includes developing standardized screening protocols for pediatric neurofibromatosis in Austria and pioneering explainable AI applications for melanoma diagnosis, reflecting a multidisciplinary approach that integrates clinical practice with computational innovation to address unmet needs in rare disease care. Analysis of his 2024–2025 publications reveals a strong emphasis on harmonizing clinical trial outcomes for Epidermolysis Bullosa, evidenced by systematic reviews and consensus guidelines. His expansion into AI-driven diagnostics marks an emerging trajectory, combining dermatological expertise with machine learning to enhance diagnostic accuracy and clinician trust—highlighting a strategic shift toward technology-integrated solutions for complex skin conditions. Scientific Awards: LEO Pharma Young Researcher Award (2023) Dr. Welponer actively collaborates with the Austrian NF network and international consortia, as demonstrated by co-authorship on multi-center studies in high-impact journals. His leadership in the Molecular Therapy of Genodermatoses program drives translational research from bench to bedside, with ongoing projects focused on outcome standardization and novel therapeutic interventions for epidermolysis bullosa. While specific grant details are not provided, his prolific publication record and industry recognition (e.g., LEO Pharma award) indicate robust funding support and growing influence in dermatological research.

• Dermatology
• Nail disorders
• Psoriasis
• +6 more

Amanda Zubek, MD, PhD, is an Assistant Professor of Dermatology at Yale School of Medicine and serves as the Director of Quality for the Department of Dermatology. She is also the Director of Yale Medicine Dermatology's Middlebury office, where she provides specialized care in dermatology with a focus on nail disorders, psoriasis, actinic keratosis, and other complex skin conditions. Education: BA in Biochemistry & Molecular Biology from Boston University (2001) PhD in Cell Biology from Northwestern University Feinberg School of Medicine (2008) MD from Northwestern University The Feinberg School of Medicine (2010) Internship at Yale New Haven Hospital (2011) Residency in Dermatology at Yale New Haven Hospital (2014) Research Interests: Dr. Zubek's research spans clinical dermatology, dermatopathology, and translational studies linking nail disorders to systemic diseases. Her work includes investigating rare nail pathologies, cutaneous manifestations of systemic syndromes like VEXAS, and the effects of biologic therapies on skin and nail health. Clinical Focus: She specializes in treating actinic keratosis, psoriasis, impetigo, acne, eczema, and nail disorders. Her patient-centered approach emphasizes education and quality-of-life improvement. Scientific Contributions: Dr. Zubek has authored numerous peer-reviewed articles, case reports, and reviews. Her recent publications highlight diagnostic clues in nail pathology, vaccine-related dermatoses, and novel therapeutic insights in inflammatory skin diseases. Teaching & Leadership: She is actively involved in training residents, medical students, and physician assistants. Her leadership roles include directing quality initiatives in dermatology and managing clinical operations at the Middlebury location.

• Dermatopathology
• Soft Tissue Pathology
• Skin Diseases Diagnosis
• +3 more

Dr. Gauri Panse serves as Associate Professor of Dermatology and Pathology at Yale School of Medicine, with primary appointment in Dermatology and secondary appointment in Pathology. She specializes in dermatopathology and soft tissue pathology, bringing expertise from fellowships completed at MD Anderson Cancer Center (bone and soft tissue pathology) and Yale (dermatopathology). Yale School of Medicine, Department of Dermatology (Primary Appointment) Yale School of Medicine, Department of Pathology (Secondary Appointment) Dermatopathology Division, Yale School of Medicine Bone & Soft Tissue Pathology, Yale School of Medicine Dr. Panse's research focuses on diagnostic approaches for skin and soft tissue diseases, with particular expertise in tumor pathology, immunohistochemistry, and rare skin conditions. Her work bridges dermatology, pathology, and oncology, with significant contributions to understanding molecular markers in skin cancer diagnosis and classification of challenging cases. Analysis of her recent publications reveals a strong emphasis on applying advanced diagnostic techniques to challenging dermatopathology cases, with growing interest in the intersection of artificial intelligence and skin disease assessment. Her work spans rare tumor entities, immunohistochemical markers, and clinical correlations between dermatological manifestations and systemic diseases. Dr. Panse serves on various committees at national societies of dermatopathology and pathology, and is a frequent lecturer at national meetings of dermatology, pathology, and dermatopathology societies. She has established productive collaborations with colleagues including Christine Ko, Shawn Cowper, Dhanpat Jain, and F. Perry Wilson across multiple research domains. Her educational background includes medical training from Topiwala National Medical College and Bai Yamunabai Laxman Nair Charitable Hospital in India, pathology residency at Baystate Medical Center, Tufts University, followed by specialized fellowships in bone and soft tissue pathology at MD Anderson Cancer Center and dermatopathology at Yale School of Medicine.

• Pediatric Dermatology
• Vascular Anomalies
• Genetic Skin Disorders
• +3 more

Dr. Sarah Elizabeth Dixon Cipriano serves as Clinical Associate Professor in Dermatology and Adjunct Associate Professor in Pediatrics at the University of Utah School of Medicine, where she holds dual leadership roles as Pediatric Dermatology Section Chief and Fellowship Director. Board-certified in Dermatology with subspecialty certification in Pediatric Dermatology, she provides specialized care at Eccles Primary Children's Outpatient Services and Primary Children's Hospital. Her educational background includes: Fellowship in Pediatric Dermatology (University of Utah) Residency in Dermatology (University of Utah) Research Fellowship in Medical Education in Dermatology (UCSF) MD with Health Professions Education Concentration (UC Berkeley/UCSF) MS in Health and Medical Sciences (UC Berkeley/UCSF) MPH in Infectious Diseases (UC Berkeley) BA in Molecular Biology and Community Studies (UC Santa Cruz) Dr. Cipriano's research integrates clinical pediatric dermatology with medical education innovation, focusing on vascular anomalies, genetic skin disorders, and autoimmune conditions. Her clinical expertise spans infantile hemangiomas, blistering disorders, and severe atopic dermatitis, with specialized involvement in tuberous sclerosis and dermatology/rheumatology clinics. She actively advances diversity in medical education through curriculum development addressing visual representation in dermatology. Analysis of her 15 most recent publications reveals strong emphasis on pediatric dermatology outcomes research, including validation of clinical scoring systems for ichthyosis and vascular anomalies, alongside educational scholarship on skin color representation and ethics training. Her work consistently appears in Pediatric Dermatology and focuses on improving care models for hospitalized children. Scientific recognition includes: 2022 School of Medicine Faculty Diversity and Inclusion Award As Fellowship Director, Dr. Cipriano mentors pediatric dermatology trainees while serving as the School of Medicine's dermatology domain expert. Her national contributions include Society for Pediatric Dermatology workforce surveys and pandemic-era treatment guidelines. She collaborates extensively with pediatric specialists across multiple disciplines to optimize complex patient care. Dr. Cipriano co-leads multidisciplinary teams including the vascular anomalies clinic, tuberous sclerosis center, and dermatology/rheumatology service at Primary Children's Hospital, integrating her expertise with pediatric subspecialists to address complex dermatological conditions in hospitalized children.

• Pediatric Cardiology
• Adult Congenital Heart Disease
• Congenital Heart Defects
• +4 more

Robert W. Elder is an Associate Professor of Pediatrics and Internal Medicine at Yale School of Medicine, specializing in Congenital Cardiology . He directs the Adult Congenital Heart Program and the Pediatric Cardiology Fellowship Program , with board certifications in Pediatric Cardiology, Internal Medicine, and Adult Congenital Heart Disease. MD: University of Connecticut School of Medicine (2005) Residency: University of Pittsburgh Medical Center Fellowship: Columbia University Medical Center Advanced Fellowship: Emory University Dr. Elder's research focuses on long-term outcomes of Fontan patients , particularly hepatic complications from Fontan circulation. His work bridges pediatric and adult congenital cardiology , emphasizing transition care and medical education . Recent studies analyze QTc prolongation in Williams Syndrome , cardiac immunology , and ethical communication in Fontan care . Scientific contributions include peer-reviewed publications in journals like Pediatric Cardiology and Circulation: Genomic and Precision Medicine . His 2024 Life and Death: A Multicenter Study examines ethical challenges in Fontan patient counseling, while the 2023 JACC Advances paper evaluates predictive accuracy for adverse events. 2017 Mae Gailani Award for Clinical Excellence 2024 Connecticut Magazine 'Top Doctors' List As Program Director for two fellowship tracks, Dr. Elder mentors future cardiologists while maintaining clinical roles in the Adult Congenital Heart Program and Pediatric Echocardiogram Program at Yale Medicine. His clinical expertise spans congenital cardiac imaging and single-ventricle physiology .

• Dermatology
• Genetic Skin Disorders
• Skin Cancer Research
• +3 more

Ulrikke Lei serves as a Clinical Associate Professor in the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her clinical practice and research are based at Gentofte Hospital (Gentofte Hospitalsvej 1, 2900 Hellerup) under the Capital Region of Denmark (Region Hovedstaden), with primary affiliation to the Department of Dermatovenerology. Her research focuses on genetic skin disorders , skin cancer epidemiology , and rare dermatological conditions . Key interests include palmoplantar keratodermas, ectodermal dysplasias, albinism syndromes, and keratinocyte carcinoma development. Her work integrates clinical dermatology with genetic analysis and population-based registry studies. Analysis of her recent publications reveals strong emphasis on translational dermatology research using Danish national registries. Her studies frequently examine geographic/socioeconomic disparities in skin cancer outcomes, genotype-phenotype correlations in genetic disorders, and innovative treatments for rare conditions. Collaborations span dermatology, ophthalmology, and genetics departments across Danish hospitals. Her research network demonstrates extensive national collaboration, particularly with the Department of Dermatology at Bispebjerg Hospital and the Department of Ophthalmology at Rigshospitalet. Current projects show significant focus on transplant dermatology and occupational skin cancer risks.

• Dermatopathology
• Cutaneous disease pathology
• Mycosis fungoides
• +7 more

Jennifer Madison McNiff, MD, is a Professor of Dermatology and Pathology at Yale School of Medicine, where she serves as Director of the Yale Dermatopathology Laboratory and Section Chief of Dermatopathology. She is an internationally recognized expert in cutaneous pathology with leadership roles in the Yale Cancer Center's Cancer Immunology Program. Her professional affiliations include past presidency of the American Society of Dermatopathology and editorial board membership for multiple specialty publications. MD, University of Vermont (1986) Residency, University of Virginia Health Services Center (1990) Chief Resident, University of Virginia Health Services Center (1991) Fellow, Medical College of Virginia (1992) Dr. McNiff's research focuses on dermatopathology with particular expertise in clinicopathologic correlations, mycosis fungoides, lupus erythematosus, graft vs. host disease, and immunofluorescence techniques. Her recent work has centered on developing precise diagnostic markers like PRAME and IRF8 to differentiate challenging skin conditions, including cutaneous lymphomas and inflammatory disorders. She has published extensively on molecular aspects of skin diseases and diagnostic pitfalls in dermatopathology. Analysis of her recent publications (2022-2024) reveals a strong focus on diagnostic immunohistochemistry, particularly PRAME applications, molecular markers for differential diagnosis, and the pathology of inflammatory and neoplastic skin conditions. Her work spans multiple disciplines including dermatopathology, immunology, oncology, and infectious disease, with emphasis on translating laboratory findings to clinical practice. Yale Medicine Distinguished Clinical Career Award (2025) Founder's Award from American Society of Dermatopathology (2024) University of Vermont Award for Academic Achievement (2021) Walter R Nickel Award for Excellence in Teaching Dermatopathology (2011) As Director of the Yale Dermatopathology Laboratory, Dr. McNiff leads a team that reviews complex cases through daily consensus conferences. The laboratory handles specimens from around the world, providing diagnoses for conditions ranging from common rashes to rare skin cancers. Her leadership has established the lab as one of the most sophisticated and technically advanced in the region, with expertise in challenging diagnostic areas including cutaneous lymphomas and autoimmune skin disorders. She collaborates extensively with clinicians across Yale Medicine to ensure accurate diagnoses that directly impact patient care. The Yale Dermatopathology Laboratory under Dr. McNiff's direction serves as a critical resource for dermatologists and oncologists, providing specialized diagnostic expertise that guides treatment decisions for complex skin conditions. The lab's work directly supports patient care at Yale Cancer Center and Yale Medicine, with particular strength in diagnosing cutaneous malignancies and inflammatory disorders.